Clinical biochemistry
-
Clinical biochemistry · Oct 2013
Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
The purpose of our study was to investigate the serum levels of soluble a-proliferation-inducing ligand (sAPRIL) in patients with colorectal cancer (CRC), benign intestinal disease and healthy volunteers and explore the potential possibility of sAPRIL severing as a CRC biomarker. ⋯ The results indicated that serum sAPRIL, as a potential biomarker, had a positive diagnostic value for colorectal cancer.